Search

everythinglearnresearchcommunity

for

Search:↓

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Improving diet may help manage sleep disorders.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Seborrheic dermatitis affects quality of life and sleep, linked to stress and nervous system changes.

BDNF, TSH, fT4, anti-TPO, and 25-OH Vitamin D levels predict depression risk in patients with autoimmune thyroiditis and hypothyroidism.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

The SBN system effectively assesses alopecia areata severity and predicts its course.

The representation of skin conditions in medical reviews partly matches their real-world impact.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

The questionnaire is valid and reliable but needs more testing for future predictions.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Scoring systems help doctors assess and treat skin diseases effectively.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Pseudofolliculitis barbae is linked to higher rates of anxiety and depression.

Kids with skin problems are more likely to have mental health issues.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.